IDEXX Laboratories, Inc. Stock

Equities

IDXX

US45168D1046

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-06-13 pm EDT 5-day change 1st Jan Change
506.1 USD -1.59% Intraday chart for IDEXX Laboratories, Inc. +1.66% -8.82%
Sales 2024 * 3.94B Sales 2025 * 4.34B Capitalization 41.8B
Net income 2024 * 922M Net income 2025 * 1.04B EV / Sales 2024 * 10.7 x
Net Debt 2024 * 396M Net Debt 2025 * 223M EV / Sales 2025 * 9.69 x
P/E ratio 2024 *
45.7 x
P/E ratio 2025 *
40.4 x
Employees 11,000
Yield 2024 *
-
Yield 2025 *
-
Free-Float 76.19%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.59%
1 week+1.66%
Current month+1.85%
1 month+0.62%
3 months-6.31%
6 months-9.23%
Current year-8.82%
More quotes
1 week
488.73
Extreme 488.73
521.52
1 month
483.02
Extreme 483.015
548.88
Current year
462.00
Extreme 462
583.39
1 year
372.50
Extreme 372.5
583.39
3 years
317.06
Extreme 317.06
706.95
5 years
168.65
Extreme 168.65
706.95
10 years
56.75
Extreme 56.745
706.95
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 12-07-31
Director of Finance/CFO 61 03-06-30
Chief Operating Officer - 07-12-31
Members of the board TitleAgeSince
Director/Board Member 71 14-03-10
Director/Board Member 73 12-07-15
Chairman 61 16-10-18
More insiders
Date Price Change Volume
24-06-13 506.1 -1.59% 463,045
24-06-12 514.3 +1.60% 414,196
24-06-11 506.2 -0.41% 348,758
24-06-10 508.3 +2.16% 565,122
24-06-07 497.5 -0.07% 380,918

Delayed Quote Nasdaq, June 13, 2024 at 04:00 pm EDT

More quotes
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.6%); - water quality analysis (4.6%); - veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.5%). Net sales by source of income break down between product sales (57.1%) and services (42.9%). Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
506.1 USD
Average target price
565.1 USD
Spread / Average Target
+11.64%
Consensus